March 24, Yingke Medical rose 5.93%, and the Bank of Communications New Vitality Flexible Allocation Hybrid Fund A held this stock as a heavy position.

Securities Star News: On March 24, Yingke Medical (300677) rose 5.93%, closing at 57.0 yuan, with a turnover rate of 3.79%, a trading volume of 176,500 lots, and a transaction value of 992 million yuan. The stock is a hot topic in concepts such as foreign trade benefits, medical devices, and COVID-19 prevention and control. Regarding capital flow data on March 24, main funds had a net inflow of 73.38 million yuan, accounting for 7.4% of the total transaction value; retail funds had a net inflow of 6.13 million yuan, accounting for 0.62%; and retail investor funds had a net outflow of 79.51 million yuan, accounting for 8.02%. Over the past five days, margin financing has had a net outflow of 70.18 million yuan, with the margin balance decreasing; securities lending net outflow was 41,800 yuan, with the securities lending balance decreasing.

The top ten public mutual funds holding Yingke Medical are listed in the table below:

In the past 90 days, six institutions have given ratings on this stock, with five recommending buy and one recommending hold; the average target price set by institutions over the past 90 days is 53.46 yuan.

According to the 2025 mutual fund annual report data on core holdings, 85 public mutual funds hold this stock, with the largest holding being China Merchants Schroder Fund’s China Merchants New Life Flexibly Managed Hybrid A. This fund currently has a scale of 3.344 billion yuan, with a latest net value of 2.191 (as of March 23), down 3.16% from the previous trading day, and up 1.48% over the past year. The current fund manager is Yang Hao.

The top ten holdings of China Merchants New Life Flexibly Managed Hybrid A are as follows:

The above information is compiled by Securities Star based on publicly available data, generated by AI algorithms (Network Credit Number 310104345710301240019), and does not constitute investment advice.